1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Flow Cytometry in Oncology and Immunology Market
Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By Type (Immunology, Oncology)
5.2.2. By Technology (Cell-based flow cytometry, Bead-based flow
cytometry)
5.2.3. By Offering (Reagents, Instruments, and Consumables Software)
5.2.4. By Application (Translational Research, Clinical
Research)
5.2.5. By End User (Hospitals, Diagnostic Laboratories, and
Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic
Research Institutes, Contract Research Organizations, and Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South
America, Middle East and Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Technology
5.3.3. By Offering
5.3.4. By Application
5.3.5. By End User
5.3.6. By Region
6.
North America Flow Cytometry in Oncology and Immunology
Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Offering
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America:
Country Analysis
6.3.1. United States Flow
Cytometry in Oncology and Immunology Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Offering
6.3.1.2.4.
By Application
6.3.1.2.5.
By End User
6.3.2. Canada Flow
Cytometry in Oncology and Immunology Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Offering
6.3.2.2.4.
By Application
6.3.2.2.5.
By End User
6.3.3. Mexico Flow Cytometry in Oncology and
Immunology Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Offering
6.3.3.2.4.
By Application
6.3.3.2.5.
By End User
7.
Europe Flow Cytometry in Oncology and Immunology Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.1.1.
By Type
7.2.1.1.2.
By Technology
7.2.1.1.3.
By Offering
7.2.1.1.4.
By Application
7.2.1.1.5.
By End User
7.2.1.1.6.
By Country
7.3. Europe: Country
Analysis
7.3.1. Germany Flow
Cytometry in Oncology and Immunology Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Offering
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.1.2.6.
By Country
7.3.2. France Flow
Cytometry in Oncology and Immunology Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Offering
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3. United Kingdom Flow
Cytometry in Oncology and Immunology Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Offering
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
7.3.4. Italy Flow Cytometry
in Oncology and Immunology Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Offering
7.3.4.2.4.
By Application
7.3.4.2.5.
By End User
7.3.5. Spain Flow Cytometry
in Oncology and Immunology Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Offering
7.3.5.2.4.
By Application
7.3.5.2.5.
By End User
8.
Asia-Pacific Flow Cytometry in Oncology and Immunology
Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1.1.1.
By Type
8.2.1.1.2.
By Technology
8.2.1.1.3.
By Offering
8.2.1.1.4.
By Application
8.2.1.1.5.
By End User
8.2.1.1.6.
By Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China Flow Cytometry
in Oncology and Immunology Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Offering
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2. Japan Flow Cytometry
in Oncology and Immunology Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Offering
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3. India Flow Cytometry
in Oncology and Immunology Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Offering
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4. South Korea Flow
Cytometry in Oncology and Immunology Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Offering
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5. Australia Flow
Cytometry in Oncology and Immunology Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Offering
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9.
South America Flow Cytometry in Oncology and Immunology
Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1.1.1.
By Type
9.2.1.1.2.
By Technology
9.2.1.1.3.
By Offering
9.2.1.1.4.
By Application
9.2.1.1.5.
By End User
9.2.1.1.6.
By Country
9.3. South America:
Country Analysis
9.3.1. Brazil Flow
Cytometry in Oncology and Immunology Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Offering
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2. Argentina Flow
Cytometry in Oncology and Immunology Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Offering
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3. Colombia Flow
Cytometry in Oncology and Immunology Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Offering
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10.
Middle East and Africa Flow Cytometry in Oncology and
Immunology Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.1.1.
By Type
10.2.1.1.2.
By Technology
10.2.1.1.3.
By Offering
10.2.1.1.4.
By Application
10.2.1.1.5.
By End User
10.2.1.1.6.
By Country
10.3.
MEA: Country Analysis
10.3.1. UAE Flow Cytometry
in Oncology and Immunology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Offering
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2. Saudi Arabia Flow
Cytometry in Oncology and Immunology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Offering
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3. South Africa Flow
Cytometry in Oncology and Immunology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Offering
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
10.3.4. Turkey Flow
Cytometry in Oncology and Immunology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Technology
10.3.4.2.3.
By Offering
10.3.4.2.4.
By Application
10.3.4.2.5.
By End User
10.3.5. Egypt Flow Cytometry
in Oncology and Immunology Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1.
By Type
10.3.5.2.2.
By Technology
10.3.5.2.3.
By Offering
10.3.5.2.4.
By Application
10.3.5.2.5.
By End User
11. Market Dynamics
11.1.
Drivers
11.1.1. Rising Prevalence of Cancer Cases
11.1.2. Advancement in Technology
11.1.3. Recent Developments & Product Launches
12. Challenges
12.1.1. High Cost of the
Products of the Flow Cytometry Equipment
12.1.2. False antibody
responses
13. Market Trends &
Developments
14. Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.5.1.
Danaher Corporation
14.5.2.
Merck KGaA
14.5.3.
Miltenyi Biotec
14.5.4.
Neo-Genomics Laboratories, Inc.
14.5.5.
Thermo Fisher Scientific Inc
14.5.6.
Cell Signaling Technology, Inc
14.5.7.
Becton, Dickinson and Company
14.5.8.
Agilent Technologies, Inc.
14.5.9.
DiaSorin S.p.A (Luminex Corporation)
14.5.10.
OPKO Health, Inc.
15. Strategic Recommendations